QUESTION AND ANSWER DOCUMENT - 2.doc
DOC document 24 KB Posted
- Solicitation number
- Reference-Number-RFQ-BARDA-08-17
View the file
Other files
| File | Type | Posted |
|---|---|---|
| QUESTION AND ANSWER DOCUMENT - 3.doc | DOC document | |
| QUESTION AND ANSWER DOCUMENT.doc | DOC document | |
| AMENDMENT 0001 RFQ-BARDA-08-17.doc | DOC document | |
| RFQ-BARDA-08-17Solicitationw-AttachCROToxMnM-final-03-31.doc | DOC document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
2nd Document of Questions and Answers on RFQ-BARDA-08-17
This document does not amend the terms and conditions of the solicitation in any manner; potential quoters have the duty to seek clarification from the contracting officer if they believe answers herein are inconsistent with the solicitation.
Questions are numbered; answers appear below the questions in italics. Questions may have been combined and/or edited for clarity.
1. Do you want a cost for every line item INCLUDING ALL THE ITEMS LISTED IN THE CLINICAL CHEMISTRY PANEL, NECROPSY PANEL, AND HISTOLOGY PANEL.
The RFQ requires pricing for each exhibit line item only. The exhibit subline items are informational only; therefore, the quoter shall not provide pricing for subline items listed in the Panels.
2. Do you want those costs referenced in question 1 above for all 3 years?
Yes, provide pricing for the base period and each of the 3 option periods for a total of 4 periods.
3. Are RFQ-BARDA-08-17 and RFQ-BARDA-08-19 linked? That is, is it BARDA’s intent that immunogenicity evaluations under -19 will be performed on samples generated from the -17 contract?
No, each of the cited solicitations is separate and distinct.
File details come from the government source that posted it. Updated .